Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
05/17/1995 | CN1028400C Smoking giving up chewing gum preparing process |
05/16/1995 | US5416205 New esters of alginic acid |
05/16/1995 | US5416116 Pediculicidal medicaments comprising derivatives of undecylenic/undecanoic acids |
05/16/1995 | US5416075 Water, oil, emulsifiers and amphipatic compound |
05/16/1995 | US5416070 Composition for macrophage activation |
05/16/1995 | US5415878 Slow release compositions |
05/16/1995 | US5415872 Compositions of gastric acid-resistant microspheres containing salts of bile acids |
05/16/1995 | US5415871 Therapeutic agents |
05/16/1995 | US5415870 Effervescent systems using reaction doping agents |
05/16/1995 | US5415869 Taxol formulation |
05/16/1995 | US5415868 Caplets with gelatin cover and process for making same |
05/16/1995 | US5415867 High ratio active agent: lipid complex |
05/16/1995 | US5415866 Viscoelastic gel pads with multilayer alcohol permeable cover with impermeable layer |
05/16/1995 | US5415864 Colonic-targeted oral drug-dosage forms based on crosslinked hydrogels containing azobonds and exhibiting PH-dependent swelling |
05/16/1995 | US5415863 Gel contains ethylenediaminetetraacetic acid and carboxypolymethylene; side effect reduction |
05/16/1995 | US5415853 Compressed gas packages using polyoxyethylene glyceryl oleates |
05/16/1995 | CA2023703C Medical electrical lead with polymeric monolithic controlled release device and method of manufacture |
05/16/1995 | CA1335573C Dispersible tablets of dihydroergotoxine and of acid addition salts thereof |
05/16/1995 | CA1335566C Ocular cyclosporin composition |
05/16/1995 | CA1335565C Liposomes: efficient loading and controlled release of amphiphatic molecules |
05/12/1995 | CA2135139A1 Topical antibacterial preparation |
05/11/1995 | WO1995012660A2 Recombinant p53 adenovirus methods and compositions |
05/11/1995 | WO1995012629A1 High molecular weight polyesterpolycarbonates and the use thereof for the preparation of bioerosible matrices |
05/11/1995 | WO1995012613A1 Metal-bonding cystein-free peptides for diagnosis and therapy, process for producing them and pharmaceutical preparations containing these compounds |
05/11/1995 | WO1995012399A1 Composition for drug delivery comprising nicotine or a derivative thereof and starch microspheres and method for the manufacturing thereof |
05/11/1995 | WO1995012397A1 Plaster for treating nail mycoses |
05/11/1995 | WO1995012393A1 Plaster for the treatment of nail mycoses |
05/11/1995 | WO1995012392A1 Biochemically active agents for chemical catalysis and cell receptor activation |
05/11/1995 | WO1995012391A1 Gelatin powders with improved tabletability. color and odor characteristics |
05/11/1995 | WO1995012390A1 Composition of herbal extracts |
05/11/1995 | WO1995012389A1 Multilamellar liposomal arachidonic acid metabolite formulations |
05/11/1995 | WO1995012388A1 Methods of treatment using unilamellar liposomal arachidonic acid metabolite formulations |
05/11/1995 | WO1995012387A1 Liposome preparation and material encapsulation method |
05/11/1995 | WO1995012386A1 Charged liposome preparation |
05/11/1995 | WO1995012385A1 Microparticular pharmaceutical compositions in micellar form |
05/11/1995 | WO1995012384A1 Self-emulsible formulation forming an oil-in-water emulsion |
05/11/1995 | WO1995012383A1 An injectable solution of testosterone undecanoate |
05/11/1995 | DE4421686A1 Liposomes containing bioavailable iron(II) and process for their preparation |
05/11/1995 | DE4336299A1 Gelatinous material for the percutaneous administration in particular of medicaments |
05/11/1995 | CA2175896A1 Methods of treatment using unilamellar liposomal arachidonic acid metabolite formulations |
05/11/1995 | CA2175057A1 Multilamellar liposomal arachidonic acid metabolite formulations |
05/11/1995 | CA2174326A1 Charged liposome preparation |
05/11/1995 | CA2174244A1 Biochemically active agents for chemical catalysis and cell receptor activation |
05/11/1995 | CA2173845A1 Metal-bonding cystein-free peptides for diagnosis and therapy, process for producing them and pharmaceutical preparations containing these compounds |
05/10/1995 | EP0652209A1 Derivatives of N-episilon alkoxy-or alkenoxy-carbonyl lysine, their preparation and use in cosmetic, pharmaceutical, hygiene or alimentary compositions |
05/10/1995 | EP0652015A2 A sustained release composition comprising a multivalent cation cross-linked algenate combined with a polyacrylic acid |
05/10/1995 | EP0652010A1 Use of alphatocopherol acetate or a derivative for the preparation of cosmetic, dermatalogical or pharmaceutical compositions with anti radical activity |
05/10/1995 | EP0652008A1 Liposome-encapsulated ciprofloxacin |
05/10/1995 | EP0651997A1 Intrabuccally disintegrating preparation and production thereof |
05/10/1995 | EP0651996A1 Equipment and process for the preparation of polymeric microcapsules containing cells producing hormones |
05/10/1995 | EP0651995A1 Cyclosporin(s) containing O/W emulsion for oral administration |
05/10/1995 | EP0651994A1 Liquid oral preparations of oil-soluble compounds |
05/10/1995 | EP0651993A1 Percutaneously administrable base composition and drug composition prepared therefrom |
05/10/1995 | EP0651984A2 Medical adhesive sheet |
05/10/1995 | EP0651765A1 Analogs of pth and pthrp, their synthesis and use for the treatment of osteoporosis |
05/10/1995 | EP0651667A1 Medication administering device |
05/10/1995 | EP0651649A1 Granulocyte colony-stimulating factor solution delivery method |
05/10/1995 | EP0651641A1 Novel bioactive compositions, preparation and use thereof |
05/10/1995 | EP0651635A1 Patch for low-melting and/or volatile active substances. |
05/10/1995 | EP0633753A4 Intra-ruminal devices. |
05/10/1995 | EP0576551B1 Novel encapsulated materials |
05/10/1995 | EP0548261B1 Spontaneously dispersible concentrate containing a sterol ester and sterol phosphatide respectively |
05/10/1995 | EP0496835B1 Solid tumor treatment method and composition |
05/10/1995 | CN1102344A All-life drug-dropping traditional Chinese medicine |
05/10/1995 | CN1102342A Radix sophorae flavescentis, large-flowered skullcap root and coptis root tablet |
05/10/1995 | CN1102337A Burn ointment |
05/10/1995 | CN1102323A Sustained release compositions and a method of preparing pharmaceutical compositions |
05/10/1995 | CN1028367C Nonsaditive antihistaminics derived from benzimidazoles |
05/10/1995 | CA2135265A1 Stable lyophilized thiotepa composition |
05/09/1995 | US5414011 Preservative system for ophthalmic formulations |
05/09/1995 | US5413995 Mannitol as excipient |
05/09/1995 | US5413804 Process for making whey-derived fat substitute product and products thereof |
05/09/1995 | US5413797 Controlled release ACTH containing microspheres |
05/09/1995 | US5413794 Drug delivery |
05/09/1995 | US5413793 Treatment of hemorrhoids with drugs in silicone oils and multilayer elements |
05/09/1995 | US5413792 Mucoadhesive polysiloxane paste-like base and preparation |
05/09/1995 | US5413782 Binding pharmaceuticals to ion exchange resins |
05/09/1995 | US5413780 Liquid skin coating or protectant |
05/09/1995 | US5413777 Pulsatile once-a-day delivery systems for minocycline |
05/09/1995 | US5413776 Pharmaceutical preparation for percutaneous absorption |
05/09/1995 | US5413774 Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof |
05/09/1995 | US5413732 Reagent compositions for analytical testing |
05/09/1995 | US5413572 Osmotic dosage system for liquid drug delivery |
05/09/1995 | CA2135374A1 Equipment and process for the preparation of polymeric microcapsules containing cells producing hormones |
05/04/1995 | WO1995011988A1 Compounds with pth activity and recombinant dna vectors encoding same |
05/04/1995 | WO1995011704A1 Liposome having oligosaccharide on the surface |
05/04/1995 | WO1995011702A1 Prokaryotic expression of mhc proteins |
05/04/1995 | WO1995011701A1 Inhibition of hiv mucosal infection |
05/04/1995 | WO1995011700A1 Submicron emulsions as vaccine adjuvants |
05/04/1995 | WO1995011690A1 Desferrioxamine oral delivery system |
05/04/1995 | WO1995011683A1 Stabilized prostaglandin e¿1? |
05/04/1995 | WO1995011679A1 Use of lobeline for the treatment of nicotine withdrawal |
05/04/1995 | WO1995011678A1 Use of nicotine substitutes for the treatment of nicotine withdrawal |
05/04/1995 | WO1995011676A1 Long-acting antifungal o/w preparation |
05/04/1995 | WO1995011674A1 Granular preparation |
05/04/1995 | WO1995011672A1 Detection of h. pylori in the stomach |
05/04/1995 | WO1995011671A1 Fast dissolving dosage forms containing magnesium aluminum silicate and multiple active ingredients |
05/04/1995 | WO1995011670A1 Liposomal defensins |
05/04/1995 | WO1995011669A1 Suspension of loteprednol etabonate |
05/04/1995 | WO1995011668A1 Gelatin capsule fill able to foam |